Olalekan Ajayi
Psychiatric/Mental Health · Baltimore, MDNPI 1962087627
Payments from drug & device makers
What this record shows
This record is dominated by education: $9,341 of the $10,413 with a category attached, or 89.7%. Bristol Myers Squibb accounts for 89.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $9,642 and has fallen 97.1% since, to $284 in 2025. Among psychiatric/mental health clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $196.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$9K
- AbbVie$434
- Supernus Pharmaceuticals, Inc.$380
- Rigel Pharmaceuticals, Inc.$135
- Tris Pharma Inc$74
- Neurocrine Biosciences, Inc.$26
- plus $23 from 1 others
What the payments were for
- Food & beverage$1,07210%
- Education$9,34190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 1 | $9,341 |
| AbbVie | 17 | $434 |
| Supernus Pharmaceuticals, Inc. | 27 | $380 |
| Rigel Pharmaceuticals, Inc. | 1 | $135 |
| Tris Pharma Inc | 4 | $74 |
| Neurocrine Biosciences, Inc. | 2 | $26 |
| Alkermes, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,413 in reported general payments places this provider in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LatudaLurasidone Hcl | 25 | $41,842 |
| VyvanseLisdexamfetamine Dimesylate | 22 | $10,440 |
| Duloxetine Hcl | 30 | $1,882 |
| Bupropion XlBupropion Hcl | 38 | $1,603 |
| Divalproex Sodium ErDivalproex Sodium | 37 | $1,582 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 21 | $1,345 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 49 | $1,187 |
| Quetiapine Fumarate | 61 | $943 |
| Buspirone Hcl | 68 | $939 |
| Aripiprazole | 40 | $852 |
| Lamotrigine | 37 | $698 |
| Fluoxetine Hcl | 47 | $697 |
| Divalproex Sodium | 18 | $625 |
| Risperidone | 44 | $480 |
| Ziprasidone Hcl | 15 | $403 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Baltimore
- Amy GrammasBaltimore$8K
- Nalo FordBaltimore$8K
- Digna Cespedes-CloudBaltimore$8K
- Gerald ChiaBaltimore$6K
- Chinwe OkudoBaltimore$6K
- Tamar RodneyBaltimore$6K
- Peter IgeBaltimore$5K
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Michelle WilliamsColumbia$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.